Personal profile
Research interests
Onderzoeksbelangen
Fingerprint
Dive into the research topics where Natasha van Eijkelenburg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial
Gray, J. C., Weston, R., Owens, C., Canete, A., Gambart, M., De Wilde, B., Nysom, K., van Eijkelenburg, N., Ladenstein, R., Castellano, A., Gerber, N. U., Marshall, L. V., Barone, G., Rubio-San-Simon, A., Ng, A., Vaidya, S., Gallego, S., Makin, G., Burke, G. A. A. & McCarthy, A. & 27 others, , 20 Jan 2026, In: Journal of Clinical Oncology. 44, 3, p. 176-187 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma
Matser, Y. A. H., van Kuilenburg, A. B. P., Samim, A., van Liempt, L. M., van Grotel, M., Kraal, K. C. J. M., Dierselhuis, M. P., van Eijkelenburg, N. K. A., Langenberg, K. P. S., van Noesel, M. M., Molenaar, J., Fiocco, M. & Tytgat, G. A. M., Mar 2026, In: JCO precision oncology. 10, 3Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium
on behalf of the Innovative Therapies For Children and Adolescents With Cancer Consortium (ITCC)., 25 Jun 2026, In: European Journal of Cancer. 242, 116830.Research output: Contribution to journal › Article › peer-review
-
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial
Gatz, S. A., Berlanga, P., Teuff, G. L., Valiev, I., Leruste, A., André, N., Bluteau, D., Corradini, N., Rubino, J., Thomas, F., Nebchi, S., Karamouza, E., Petit, J., Thebaud, E., Rubio-San-Simón, A., van Eijkelenburg, N. K. A., Marshall, L. V., Raimbault, S., Canete, A. & Ducassou, S. & 19 others, , 1 Apr 2026, In: Clinical Cancer Research. 32, 7, p. 1210-1223 14 p.Research output: Contribution to journal › Article › peer-review
-
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]
Langenberg, K. P. S., Meister, M. T., Bakhuizen, J. J., Boer, J. M., van Eijkelenburg, N. K. A., Hulleman, E., Ilan, U., Looze, E. J., Dierselhuis, M. P., Lugt, J. V. D., Breunis, W., Schild, L. G., Ober, K., van Hooff, S. R., Scheijde-Vermeulen, M. A., Hiemcke-Jiwa, L. S., Flucke, U. E., Kranendonk, M. E. G., Wesseling, P. & Sonneveld, E. & 34 others, , 15 May 2025, In: European Journal of Cancer. 221, 115423.Research output: Contribution to journal › Comment/debate
Open Access1 Citation (Scopus)